[1]冷朝会,李雪莲,刘 俊,等.热休克蛋白90α、β2-微球蛋白及胃泌素释放肽前体在肺癌患者血清中的表达水平及检测意义[J].陕西医学杂志,2024,(8):1110-1113.[doi:DOI:10.3969/j.issn.1000-7377.2024.08.023]
　LENG Chaohui,LI Xuelian,LIU Jun,et al.Expression levels and significance of heat shock protein 90α,β2-microglobulin and pro-gastrin releasing peptide in the serum of patients with lung cancer[J].,2024,(8):1110-1113.[doi:DOI:10.3969/j.issn.1000-7377.2024.08.023]
点击复制

热休克蛋白90α、β2-微球蛋白及胃泌素释放肽前体在肺癌患者血清中的表达水平及检测意义
分享到：

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
期数:
2024年8期
页码:
1110-1113
栏目:
临床检验
出版日期:
2024-08-05

文章信息/Info

Title:
Expression levels and significance of heat shock protein 90α,β2-microglobulin and pro-gastrin releasing peptide in the serum of patients with lung cancer
作者:
冷朝会1; 李雪莲1; 刘 俊1; 丁光明1; 陈 丹2
(1.成都市第六人民医院老年医学科,四川 成都 610503; 2.成都市第六人民医院肾内科,四川 成都 610503)
Author(s):
LENG Chaohui; LI Xuelian; LIU Jun; DING Guangming; CHEN Dan
(Department of Geriatrics,the Sixth People's Hospital of Chengdu,Chengdu 610503,China)
关键词:
肺癌;  热休克蛋白90α;  β2-微球蛋白;  胃泌素释放肽前体;  诊断价值
Keywords:
Lung cancer;  Heat shock protein 90α;  β2-microglobulin;  Pro-gastrin releasing peptide;  Diagnostic value
分类号:
R 734.2
DOI:
DOI:10.3969/j.issn.1000-7377.2024.08.023
文献标志码:
A
摘要:
目的:探讨热休克蛋白90α(HSP90α)、β2-微球蛋白(β2-MG)及胃泌素释放肽前体(ProGRP)在肺癌患者血清中的表达水平及检测意义。方法:选取接受诊治的肺癌患者133例为肺癌组,另选择肺部良性结节患者106例(良性肺病组)及体检健康者112例(对照组)。比较三组血清HSP90α、β2-MG、ProGRP水平,并分析HSP90α、β2-MG、ProGRP对肺癌的诊断价值; 比较肺癌组不同病理类型患者血清HSP90α、β2-MG、ProGRP阳性检出率以及肺癌组化疗后不同疗效患者血清HSP90α、β2-MG、ProGRP水平。结果:肺癌组血清HSP90α、β2-MG、ProGRP水平高于对照组、良性肺病组(均P<0.05)。血清HSP90α、β2-MG、ProGRP联合检测肺癌的AUC为0.861,高于三者单独检测的AUC(均P<0.05)。血清HSP90α、β2-MG在NSCLC阳性检出率高于SCLC,血清ProGRP在SCLC阳性检出率高于NSCLC(均P<0.05)。肺癌组化疗后,无效患者血清HSP90α、β2-MG、ProGRP水平高于有效和稳定患者(均P<0.05)。稳定患者血清HSP90α、β2-MG、ProGRP水平高于有效患者(均P<0.05)。结论:肺癌患者血清HSP90α、β2-MG、ProGRP水平升高,且与不同病理类型和化疗效果有关,三者联合检测对肺癌诊断价值较高。
Abstract:
Objective:To investigate the expression levels and significance of heat shock protein 90α(HSP90α),β2-microglobulin(β2-MG)and pro-gastrin releasing peptide(ProGRP)in the serum of patients with lung cancer.Methods:A total of 133 lung cancer patients were selected as the lung cancer group.In addition,106 patients with benign lung nodules(benign lung disease group)and 112 healthy subjects(control group)were selected.The serum levels of HSP90α,β2-MG and ProGRP were compared between the three groups.The diagnostic value of HSP90α,β2-MG and ProGRP in lung cancer was analyzed.The positive detection rates of serum HSP90α,β2-MG and ProGRP in patients with different pathological types in the lung cancer group were compared.After chemotherapy,the serum levels of HSP90α,β2-MG and ProGRP in patients with different efficacy were compared in the lung cancer group.Results:The serum levels of HSP90α,β2-MG and ProGRP in the lung cancer group were higher than those in the control group and the benign lung disease group(all P<0.05).The AUC of combined detection of serum HSP90α,β2-MG and ProGRP in lung cancer was 0.861,which was higher than that of the three alone(all P<0.05).The positive detection rates of serum HSP90α and β2-MG in NSCLC were higher than those in SCLC,and the positive detection rate of serum ProGRP in SCLC was higher than that in NSCLC(all P<0.05).After chemotherapy,the serum levels of HSP90α,β2-MG and ProGRP in the ineffective patients were higher than those in the effective and stable patients(all P<0.05).The serum levels of HSP90α,β2-MG and ProGRP in stable patients were higher than those in effective patients(all P<0.05).Conclusion:The serum levels of HSP90α,β2-MG and ProGRP in lung cancer patients are increased,which are related to different pathological types and chemotherapy effects,and the combination of the three has high diagnostic value for lung cancer.

参考文献/References:

[1] 林帅,房娜,姜雯雯,等.18F-FDG PET/CT联合肿瘤标志物ProGRP与NSE在ⅠA期小细胞肺癌诊断及鉴别诊断中的价值[J].中华核医学与分子影像杂志,2023,43(6):355-359.
[2] 吴骥,范敏,江国豪,等.18F-FDG PET/CT联合血清神经元特异性烯醇化酶及胃泌素释放肽前体诊断小细胞肺癌[J].中国医学影像技术,2021,37(2):235-239.
[3] 朱冬菊,朴炳奎,秦腾腾,等.基于PI3K/Akt信号通路探讨固本解毒方含药血清对肺癌A549细胞EMT的影响[J].中国实验方剂学杂志,2022,28(22):93-99.
[4] 吴颖虹,王仁杰,胡文杰,等.循环肿瘤细胞在晚期非小细胞肺癌顺铂联合多西他赛化疗疗效评价和预后评估中的作用[J].中国老年学杂志,2022,42(7):1593-1595.
[5] TORII Y,YAMADA S,YAJIMA M,et al.Polymethylmethacrylate membrane dialyzer:Historic but modern[J].Blood Purif,2022,52(Suppl 1):1-7.
[6] BARABUTIS N.Heat shock protein 90 inhibition in the inflamed lungs[J].Cell Stress Chaperones,2020,25(2):195-197.
[7] 复旦大学出版社隆重推出《现代肿瘤学》第3版[J].复旦学报(医学版),2011,38(5):412.
[8] SHEN Y,CHEN W,HAN L,et al.VEGF-B antibody and interleukin-22 fusion protein ameliorates diabetic nephropathy through inhibiting lipid accumulation and inflammatory responses[J].Acta Pharm Sin B,2021,11(1):127-142.
[9] 蒋琼慧,路泽军,杨平.肿瘤免疫治疗疗效评价标准——iRECIST解读[J].转化医学杂志,2020,9(1):57-60.
[10] 吴福林,吴伟乐斯.非小细胞肺癌患者癌组织和血清中SKA3、G3 BP2、PROX1表达与临床治疗的关系[J].中国老年学杂志,2023,43(17):4136-4138.
[11] 曾攀科,王立升.基于热休克蛋白90靶点的苦参碱衍生物C4对非小细胞肺癌细胞迁移、侵袭及凋亡的影响[J].中国实验方剂学杂志,2022,28(23):71-78.
[12] 董晓玉,钟涛,叶元滋,等.血清HSP90α和癌组织基因HSP90AA1在肺癌中的高表达及预后价值[J].安徽医科大学学报,2022,57(7):1034-1040.
[13] VISSER E,GENET S A A M,DE-KOCK R P P A,et al.Liquid biopsy-based decision support algorithms for diagnosis and subtyping of lung cancer[J].Lung Cancer,2023,178:28-36.
[14] CAO J,HOU R,LU J,et al.The predictive value of β2-MG and TGF-β for elderly hypertensive nephropathy[J].Exp Ther Med,2019,17(4):3065-3070.
[15] 姚智芬,李欢,曹柳.类风湿关节炎血清中PGRN对肺癌细胞免疫逃逸的作用[J].生物技术,2023,33(4):508-515.
[16] GIOVANELLA L,FONTANA M,KELLER F,et al.Circulating pro-gastrin releasing peptide(ProGRP)in patients with medullary thyroid carcinoma[J].Clin Chem Lab Med,2021,59(9):1569-1573.
[17] YU M,YANG C,WANG S,et al.Serum ProGRP as a novel biomarker of bone metastasis in prostate cancer[J].Clin Chim Acta,2020,510:437-441.
[18] DONG A,ZHANG J,CHEN X,et al.Diagnostic value of ProGRP for small cell lung cancer in different stages[J].J Thorac Dis,2019,11(4):1182-1189.
[19] 宁永波,王雅兴,陈香颖,等.名中医王瑞平“期证相合”理论在肺癌术后研究肿瘤微环境经验[J].陕西中医,2023,44(10):1448-1451.
[20] 屈直,王芬,李志明,等.二陈汤对Lewis肺癌移植瘤生长及Hedgehog通路蛋白表达的影响[J].陕西中医,2022,43(5):555-558,563.
[21] 孔凡龙,吴宝,信洪武,等.裸鼠肺腺癌移植瘤组织中缺氧诱导因子-1α蛋白、血清蛋白和淋巴管内皮细胞透明质酸受体1蛋白表达及意义[J].陕西医学杂志,2022,51(12):1472-1476,1482.
[22] 郭家毓,呼群.小细胞肺癌免疫治疗研究进展[J].陕西医学杂志,2023,52(1):118-120,封3.
[23] 杨泽利,周庆涛,孙永昌.血清肺癌标志物水平与脓毒症病情和预后的相关性[J].中华医院感染学杂志,2022,32(3):360-364.
[24] 堵红群,殷允娟,邢炯,等.多层螺旋CT、IVIM-DWI结合血清CEA、SCCA对肺炎性假瘤、周围型肺癌的诊断价值[J].实用放射学杂志,2022,38(7):1078-1081.
[25] 谭双,李相华,刘春芹,等.缺血性脑卒中后认知障碍患者血清肺腺癌转移相关转录因子-1及硫氧还蛋白互作蛋白水平的变化及意义[J].中国现代医学杂志,2022,32(13):26-31.

相似文献/References:

[1]贾丽娟,杜苏丰.重组新城疫病毒疫苗rlRVG对A549荷瘤小鼠瘤体生长的抑制作用[J].陕西医学杂志,2019,(1):6.
　JIA Lijuan,DU Sufeng..The tumor growth influence of recombinant NDV (rlRVG) on lung adenocarcinoma A549transfected in vivo[J].,2019,(8):6.
[2]江茂琼,贾钰铭△,叶文静,等.MDSCs对肺癌小鼠CD8+T细胞及生存期的影响研究[J].陕西医学杂志,2019,(3):293.
　JIANG Maoqiong,JIA Yuming,LI Ting,et al.Effect of MDSCs on CD8 T cells and survival time of lung cancer mice[J].,2019,(8):293.
[3]李君艳,陈国荣.肺癌患者凝血指标与临床特征的关系*[J].陕西医学杂志,2019,(6):718.
　LI Junyan,CHEN Guorong..The relationships between coagulation indicators and clinic characterisitics of patients with lung cancer[J].,2019,(8):718.
[4]王 玲,申 鸿.癌胚抗原、糖类抗原、CA125、血管生成素、细胞角蛋白19片段及甲胎蛋白检测在肺癌诊断中的临床研究*[J].陕西医学杂志,2019,(8):1080.
　WANG Ling,SHEN Hong..The value of tumor markers CEA，CA199，CA125，Ang-2，CYFRA211 and AFP in the diagnosis of lung cancer[J].,2019,(8):1080.
[5]韩 乐,陈文娟△,雷光焰,等.microRNA21、microRNA25在肺癌组织中的表达及意义*[J].陕西医学杂志,2019,(12):1596.
　HAN Le,CHEN Wenjuan,LEI Guangyan,et al.Expression and significance of microRNA21 and microRNA25 in lung cancer tissues[J].,2019,(8):1596.
[6]王 勇,张 勇,白正忠△.单操作孔完全胸腔镜与传统三孔胸腔镜治疗老年肺癌疗效对比研究*[J].陕西医学杂志,2019,(12):1670.
[7]常瑞霞,可春梅.血小板相关参数和凝血指标在肺癌治疗中的变化及意义[J].陕西医学杂志,2021,50(5):610.[doi:DOI:10.3969/j.issn.1000-7377.2021.05.024]
　CHANG Ruixia,KE Chunmei.Changes and significance of platelet-related parameters and coagulation indexes in treatment of lung cancer[J].,2021,50(8):610.[doi:DOI:10.3969/j.issn.1000-7377.2021.05.024]
[8]米卫国.负压引流管在单操作孔胸腔镜下肺癌根治术中的临床应用研究[J].陕西医学杂志,2021,50(7):839.[doi:DOI:10.3969/j.issn.1000-7377.2021.07.018]
　MI Weiguo.Application effect of negative pressure drainage tube in patients undergoing radical surgery for lung cancer under single-port thoracoscopy[J].,2021,50(8):839.[doi:DOI:10.3969/j.issn.1000-7377.2021.07.018]
[9]张玉琨,李 波,刘 静,等.迷走神经保护对胸腔镜下肺癌根治术后房颤发生的预防作用[J].陕西医学杂志,2021,50(10):1267.[doi:DOI:10.3969/j.issn.1000-7377.2021.10.023]
[10]米 婷,王雅宁.气管镜下宏基因组学二代测序技术在肺癌鉴别诊断中的临床应用价值[J].陕西医学杂志,2022,51(4):437.[doi:DOI:10.3969/j.issn.1000-7377.2022.04.012]

备注/Memo

备注/Memo:
基金项目:四川省医学(青年创新)科研课题(Q22059)
更新日期/Last Update: 2024-08-08